Developer docs
API playgroundTry for free, no card

Search company profiles

Ameritox

Full company profile

uuid000eojr

Namestring
Ameritox
Websiteurl
ameritox.com
Company typeenum
Private
Founded yearint
1996
Descriptiontext

Ameritox is a clinical laboratory services company headquartered in Baltimore, Maryland, founded in 1996, that provides urine drug testing and pain medication monitoring services. The company's core offering supports physicians — primarily those practicing pain management — by delivering objective toxicology results that help assess whether patients are adhering to prescribed pain medication regimens and not using non-prescribed or illicit substances. With 251-500 employees and a private ownership structure, Ameritox operates in the specialized clinical toxicology segment of the diagnostics market.

The company's product is built around laboratory-based urine specimen analysis paired with clinician-oriented reporting, a workflow designed to integrate into prescribing-physician decision-making. Reimbursement for clinical toxicology services from third-party payors is the implied revenue mechanic, and the go-to-market is B2B, targeting prescribers and pain management practices. The 2007 financing from Bain Capital Ventures and Sequoia Capital indicates that at that point Ameritox had reached a scale attractive to growth-equity investors in the healthcare services space. The current product portfolio, technology stack, payor mix, and competitive positioning are not described in the available input beyond the high-level statement that Ameritox conducts urine drug tests and supports pain medication monitoring.

Short descriptiontext

Ameritox is a Baltimore-based clinical laboratory founded in 1996 that provides urine drug testing and pain medication monitoring services to prescribing physicians, primarily in pain management practice, with 251-500 employees.

Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersBaltimore, United States
HQ citystring
Baltimore
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
urine drug testing, pain medication monitoring, medication monitoring services, clinical toxicology laboratory, opioid adherence screening
Industry2 codes
1Drug-of-Abuse & Toxicology Rapid Tests (Urine/saliva panels)
CodeHLAHAOAGPrimaryYes
2Urinalysis & Routine Screening Diagnostics
CodeHLAHAAAGPrimaryNo
NAICS code2 codes
  • Medical Laboratories621511
  • Medical and Diagnostic Laboratories62151
SIC code1 code
  • Services-Medical Laboratories8071
Product category
Clinical Laboratory Services
Social media profiles2 records
Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Ameritox performs urine drug tests and provides pain medication monitoring services to support physicians managing patients on chronic pain therapy. The company delivers laboratory results with clinical interpretation to help prescribers monitor adherence, detect illicit substances, and support safer opioid prescribing.

Differentiator
Functional benefit
Problem solved
Product and service2 records
1Urine Drug Testing Service
CategoryClinical laboratory services
Description

Clinical laboratory urine drug testing service used by healthcare providers to detect prescribed medications, non-prescribed substances, and illicit drugs in patients. Designed for physicians and pain management practices that need objective toxicology evidence to guide therapy decisions.

2Pain Medication Monitoring Program
CategoryClinical laboratory services
Description

Medication monitoring program built around urine drug testing results, with clinical interpretation delivered to prescribers managing patients on long-term pain therapy. Aimed at supporting safe opioid prescribing and adherence monitoring.

Recent move2 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight1 record

Each record includes

Type, Description

Peers10 records
1Millennium Health
TypeDirect peer
Description

Millennium Health is a specialty toxicology laboratory focused on urine drug testing and medication monitoring for pain and behavioral-health providers, directly overlapping Ameritox's core offering, customer base, and clinical-reporting workflow.

2Aegis Sciences Corporation
TypeDirect peer
Description

Aegis Sciences is a Nashville-based clinical laboratory specializing in toxicology, including urine drug testing for pain management and substance-use disorder treatment, competing head-to-head with Ameritox for physician accounts.

3Dominion Diagnostics
TypeDirect peer
Description

Dominion Diagnostics operated a specialty urine drug testing lab serving pain-management prescribers with similar clinical-reporting services to Ameritox, making it a closely comparable niche competitor.

4US Drug Testing Laboratories (USDTL)
TypeDirect peer
Description

USDTL is a specialty reference laboratory offering urine, hair, and oral-fluid drug testing with particular depth in pain-management and perinatal toxicology — directly comparable clinical focus to Ameritox.

5Acutis Diagnostics
TypeDirect peer
Description

Acutis Diagnostics is a clinical laboratory with a strong toxicology and infectious-disease testing menu, including pain-medication urine drug testing sold into similar physician and addiction-medicine channels.

6Cordant Health Solutions
TypeDirect peer
Description

Cordant Health Solutions provides urine drug testing, medication monitoring, and behavioral-health laboratory services, overlapping with Ameritox in pain-management toxicology and addiction-medicine testing.

7Quest Diagnostics
TypeBroad incumbent
Description

Quest Diagnostics is a national reference laboratory with an extensive toxicology menu including urine drug testing; it competes broadly with Ameritox but does not specialize in pain-management clinical reporting.

8Laboratory Corporation of America (LabCorp)
TypeBroad incumbent
Description

LabCorp is one of the largest U.S. clinical reference labs and offers broad toxicology panels, competing with Ameritox for in-network physician and health-system volume while serving many other testing categories.

9Psychemedics Corporation
TypeBroad incumbent
Description

Psychemedics is a commercial drug-testing laboratory best known for hair-based testing but operates in the broader toxicology space adjacent to Ameritox's urine-based pain-management focus.

10Abbott Toxicology (Alere Toxicology)
TypeBroad incumbent
Description

Abbott (through its Alere acquisition) supplies point-of-care and lab-based toxicology products, competing with Ameritox across drug-of-abuse testing workflows from a diversified diagnostics-instrument manufacturer base.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Ameritox

Clinical Laboratory Servicesameritox.com

Ameritox is a Baltimore-based clinical laboratory founded in 1996 that provides urine drug testing and pain medication monitoring services to prescribing physicians, primarily in pain management practice, with 251-500 employees.

What Ameritox does

Ameritox is a clinical laboratory services company headquartered in Baltimore, Maryland, founded in 1996, that provides urine drug testing and pain medication monitoring services. The company's core offering supports physicians — primarily those practicing pain management — by delivering objective toxicology results that help assess whether patients are adhering to prescribed pain medication regimens and not using non-prescribed or illicit substances. With 251-500 employees and a private ownership structure, Ameritox operates in the specialized clinical toxicology segment of the diagnostics market.

The company's product is built around laboratory-based urine specimen analysis paired with clinician-oriented reporting, a workflow designed to integrate into prescribing-physician decision-making. Reimbursement for clinical toxicology services from third-party payors is the implied revenue mechanic, and the go-to-market is B2B, targeting prescribers and pain management practices. The 2007 financing from Bain Capital Ventures and Sequoia Capital indicates that at that point Ameritox had reached a scale attractive to growth-equity investors in the healthcare services space. The current product portfolio, technology stack, payor mix, and competitive positioning are not described in the available input beyond the high-level statement that Ameritox conducts urine drug tests and supports pain medication monitoring.

Ameritox firmographics

Firmographics
Name
Ameritox
Website
https://ameritox.com
Company type
Private
Founded year
1996
Headcount range
251–500 employees
Short description
Ameritox is a Baltimore-based clinical laboratory founded in 1996 that provides urine drug testing and pain medication monitoring services to prescribing physicians, primarily in pain management practice, with 251-500 employees.
Ownership category
akta.pro rank

Ameritox industry classification

Industry
Product category
Clinical Laboratory Services
NAICS
Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151)
SIC
Services-Medical Laboratories (8071)
akta.pro primary industry
Drug-of-Abuse & Toxicology Rapid Tests (Urine/saliva panels) (HLAHAOAG)
akta.pro secondary industry
Urinalysis & Routine Screening Diagnostics (HLAHAAAG)

Keywords

  • Urine drug testing
  • Pain medication monitoring
  • Medication monitoring services
  • Clinical toxicology laboratory
  • Opioid adherence screening

Where Ameritox is headquartered

Location

Headquarters

HQ city
Baltimore
HQ country
United States
HQ region
North America

Markets served

Ameritox business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain

Ameritox product offering

Product offering

Core offering

Ameritox performs urine drug tests and provides pain medication monitoring services to support physicians managing patients on chronic pain therapy. The company delivers laboratory results with clinical interpretation to help prescribers monitor adherence, detect illicit substances, and support safer opioid prescribing.

Differentiator

Problem solved

Functional benefit

Products and services

  • Urine Drug Testing Service Clinical laboratory urine drug testing service used by healthcare providers to detect prescribed medications, non-prescribed substances, and illicit drugs in patients. Designed for physicians and pain management practices that need objective toxicology evidence to guide therapy decisions.
  • Pain Medication Monitoring Program Medication monitoring program built around urine drug testing results, with clinical interpretation delivered to prescribers managing patients on long-term pain therapy. Aimed at supporting safe opioid prescribing and adherence monitoring.

Companies that use Ameritox

Customer profile

Ideal customer profiles1 record

Ameritox technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Ameritox partnerships and signals

Strategic signal

Recent moves2 records

Expansion highlights1 record

Ameritox competitors and assessment

Company assessment

Direct peers

  • Millennium Health: Millennium Health is a specialty toxicology laboratory focused on urine drug testing and medication monitoring for pain and behavioral-health providers, directly overlapping Ameritox's core offering, customer base, and clinical-reporting workflow.
  • Aegis Sciences Corporation: Aegis Sciences is a Nashville-based clinical laboratory specializing in toxicology, including urine drug testing for pain management and substance-use disorder treatment, competing head-to-head with Ameritox for physician accounts.
  • Dominion Diagnostics: Dominion Diagnostics operated a specialty urine drug testing lab serving pain-management prescribers with similar clinical-reporting services to Ameritox, making it a closely comparable niche competitor.
  • US Drug Testing Laboratories (USDTL): USDTL is a specialty reference laboratory offering urine, hair, and oral-fluid drug testing with particular depth in pain-management and perinatal toxicology — directly comparable clinical focus to Ameritox.
  • Acutis Diagnostics: Acutis Diagnostics is a clinical laboratory with a strong toxicology and infectious-disease testing menu, including pain-medication urine drug testing sold into similar physician and addiction-medicine channels.
  • Cordant Health Solutions: Cordant Health Solutions provides urine drug testing, medication monitoring, and behavioral-health laboratory services, overlapping with Ameritox in pain-management toxicology and addiction-medicine testing.

Broad incumbents

  • Quest Diagnostics: Quest Diagnostics is a national reference laboratory with an extensive toxicology menu including urine drug testing; it competes broadly with Ameritox but does not specialize in pain-management clinical reporting.
  • Laboratory Corporation of America (LabCorp): LabCorp is one of the largest U.S. clinical reference labs and offers broad toxicology panels, competing with Ameritox for in-network physician and health-system volume while serving many other testing categories.
  • Psychemedics Corporation: Psychemedics is a commercial drug-testing laboratory best known for hair-based testing but operates in the broader toxicology space adjacent to Ameritox's urine-based pain-management focus.
  • Abbott Toxicology (Alere Toxicology): Abbott (through its Alere acquisition) supplies point-of-care and lab-based toxicology products, competing with Ameritox across drug-of-abuse testing workflows from a diversified diagnostics-instrument manufacturer base.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

Ameritox social profiles

Digital presence

Ameritox financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Ameritox leadership team

Management profile

Number of profiles

Profiles1 record

Ameritox funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Ameritox M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ameritox

What does Ameritox do?

Ameritox performs urine drug tests and provides pain medication monitoring services to support physicians managing patients on chronic pain therapy. The company delivers laboratory results with clinical interpretation to help prescribers monitor adherence, detect illicit substances, and support safer opioid prescribing.

When was Ameritox founded?

Ameritox was founded in 1996. It employs 251 to 500 people.

Where is Ameritox based?

Ameritox is headquartered in Baltimore, United States, in the North America region.

Who are Ameritox's main competitors?

Direct peers on record are Millennium Health, Aegis Sciences Corporation, Dominion Diagnostics, US Drug Testing Laboratories (USDTL), Acutis Diagnostics and Cordant Health Solutions. Broad incumbents are Quest Diagnostics, Laboratory Corporation of America (LabCorp), Psychemedics Corporation and Abbott Toxicology (Alere Toxicology).

Does Ameritox have an API?

No public API is recorded for Ameritox.

What industry is Ameritox in?

Ameritox's product category is Clinical Laboratory Services. Its primary akta.pro industry code is HLAHAOAG, Drug-of-Abuse & Toxicology Rapid Tests (Urine/saliva panels), with a secondary code of HLAHAAAG, Urinalysis & Routine Screening Diagnostics. Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireAmeritox: National Public Health Emergency Declaration for Opioid Epidemic Important Step to Halting CrisisPresident Donald J. Trump declared the opioid crisis a national public health emergency on October 26, 2017, prompting Ameritox, a medication monitoring solutions company, to applaud the decision. Ameritox CEO Todd Gardner stated that medication monitoring can be an effective tool in combating the epidemic and noted that appropriate prescribing combined with monitoring can improve clinical outcomes and lower costs. The company also referenced its recent letter to House Committee leaders supporting Jessie's Law, legislation aimed at facilitating conversations about opioid addiction between clinicians and patients that has passed the Senate and awaits House action.PR NewswireAmeritox's Ingenuity Health Announces Research Study from UCLA Center for Health Services and SocietyAmeritox's Ingenuity Health has commissioned a research study by the UCLA Center for Health Services and Society to establish clinical guidelines for urine drug monitoring in patients with serious mental illnesses. The study aims to enhance understanding of how this monitoring is currently used by clinicians and its impact on patient treatment. Findings from the study will be jointly announced by Ameritox and the UCLA Center.PR NewswireAmeritox Study on ADHD Medication Behavior in Adolescents Reveals Which Drug is More Likely to be Misused or DivertedAmeritox, through its subsidiary Ingenuity Health, released research showing that 35 percent of patients aged 6 to 25 tested negative for their prescribed amphetamine ADHD medication, compared to 26 percent for methylphenidate. The study, based on urine samples collected over 16 months, found that nearly 33 percent of patients were not taking their prescribed ADHD medication as directed. Ameritox presented these findings at the American Academy of Child and Adolescent Psychiatry conference in New York, suggesting that amphetamine drugs are more likely to be misused or diverted than methylphenidate.PR NewswireAmeritox: Ingenuity Health Releases Updated Data Revealing Persistent Problem of Medication Non-adherence Among Those with Serious Mental IllnessAmeritox released updated research data revealing that nearly 25 percent of patients with Serious Mental Illness tested negative for their prescribed antipsychotic medications. The study, based on over 62,000 samples, also identified significant misuse of benzodiazepines and non-prescribed antipsychotics among this population. This finding highlights persistent challenges in medication adherence and the risks of dangerous drug interactions.PR NewswireAmeritox Investments in Testing Capabilities Gives Doctors New Insights into Flakka and KratomAmeritox, a national medication monitoring company headquartered in Baltimore, announced it is now offering laboratory tests for flakka and Kratom, two street drugs flagged by clinicians and law enforcement as substances of concern among prescription drug abusers. The company obtained reference standards to calibrate its testing equipment after monitoring DEA notices and identifying a growing need among physicians treating patients at risk. Ameritox Chief Medical Officer Dr. Tom Smith noted that the effects of these drugs are not yet fully understood, and the testing capability aims to help protect patients from potential harm.PR NewswireAmeritox Partners for Third Year With Operation UNITE Youth Basketball Camps Focused on Drug Abuse PreventionAmeritox, a national leader in medication monitoring solutions, announced it will sponsor for the third consecutive year a series of basketball camps organized by Kentucky-based Operation UNITE, a nonprofit created by Congressman Hal Rogers in 2003 to combat drug abuse in Eastern Kentucky. The five free 2016 camps will be led by former University of Kentucky basketball stars Jeff Sheppard and Jarrod Polson, combining basketball skills training with anti-drug messages aimed at preventing opioid misuse among school-aged youth. Ameritox employees will provide on-site support at the camps, which are being held at various schools across Eastern Kentucky.PR NewswireAmeritox Presents Research That Reveals Patients' Illicit Substance Abuse Differs Among Types of Insurance CoverageAmeritox presented research at the American Pain Society annual meeting analyzing over 450,000 patient samples to demonstrate that illicit substance abuse rates vary significantly by insurance payer type. The data revealed that Medicaid-covered patients had an illicit substance detection rate of more than 16 percent, nearly double that of patients with commercial insurance, workers' compensation, or Medicare.PR NewswireAmeritox Data on ADHD Stimulant Prescriptions Uncovers Significant Rates of Illicit Drug Use and Potential Nonadherence to Drug RegimenAmeritox presented research at the APSARD Annual Meeting in Washington showing that among more than 4,000 ADHD patients prescribed stimulants, approximately one in three samples had no detectable level of the prescribed drug. The study found that among samples where the prescribed stimulant was absent, THC was detected in over 20% of cases and nearly 40% showed presence of nonprescribed opioids, benzodiazepines, THC, or cocaine. Patients aged 20-29 had the highest rates of potential nonadherence at over 40%, while patients over 60 had the lowest at 24.4%.